APA (7th ed.) Citation

DS, P., EA, D., & RH, S. (2002). Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. Pharmacotherapy, 22(2), 166. https://doi.org/10.1592/phco.22.3.166.33548

Chicago Style (17th ed.) Citation

DS, Pathak, Davis EA, and Stanford RH. "Economic Impact of Asthma Therapy with Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population." Pharmacotherapy 22, no. 2 (2002): 166. https://doi.org/10.1592/phco.22.3.166.33548.

MLA (9th ed.) Citation

DS, Pathak, et al. "Economic Impact of Asthma Therapy with Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population." Pharmacotherapy, vol. 22, no. 2, 2002, p. 166, https://doi.org/10.1592/phco.22.3.166.33548.